The Impact of Differing Gleason Scores at Biopsy on the Odds of Upgrading and the Risk of Death from Prostate Cancer

BACKGROUND: The Gleason score (GS) is an established prostate cancer (PCa) prognostic factor. Whether the presence of differing GS’s at biopsy (e.g. 4 + 3 and 3 + 3), which we term ComboGS, improves the prognosis that would be predicted based on the highest GS (e.g.4 + 3) due to decreased upgrading...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Phillips, John G, Aizer, Ayal A, Chen, Ming-Hui, Zhang, Danjie, Hirsch, Michelle S, Richie, Jerome P, Tempany, Clare M, Williams, Stephen, Hegde, John V, Loffredo, Marian, D’Amico, Anthony V
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153802/
https://ncbi.nlm.nih.gov/pubmed/24721618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2014.02.008
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller